Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 7/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | CA9 | Q16790 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3801496 | 1.00 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL27997210 | 1.00 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL20476841 | 1.00 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL2012475 | 1.00 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL28419458 | 1.00 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL29550937 | 0.98 | PYGB (0.49) | PYGBGAACA12CA1CA2 | |
| SCHEMBL7048684 | 0.87 | PYGB (0.49) | PYGBGAACA12CA1CA2 | |
| SCHEMBL2848040 | 0.86 | PYGB (0.44) | PYGBGAACA12CA1CA2 | |
| SCHEMBL4006332 | 0.86 | PYGB (0.44) | PYGBGAACA12CA1CA2 | |
| SCHEMBL670576 | 0.86 | PYGB (0.44) | PYGBGAACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727356-A2 | SYNTHETIC ANTIFREEZE GLYCOPROTEINS WITH ICE-BINDING ACTIVITY | University of Utah Research Foundation (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024258965-A2 | SYNTHETIC ANTIFREEZE GLYCOPROTEINS WITH ICE-BINDING ACTIVITY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20230256080-A1 | VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS | UNIV MICHIGAN STATE (US) | 2023-08-17 | — | — | US | disclosed |
| US-8871468-B2 | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins | OHIO UNIVERSITY (US) | 2014-10-28 | — | — | US | disclosed |
| US-20140287457-A9 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS | NATIONAL SCIENCE FOUNDATION | 2014-09-25 | — | — | US | disclosed |
| US-8623812-B2 | Cross-linkable glycoproteins and methods of making the same | OHIO UNIVERSITY (US) | 2014-01-07 | — | — | US | disclosed |
| US-8563687-B2 | Synthetic genes for plant gums and other hydroxyproline rich glycoproteins | OHIO UNIVERSITY (US) | 2013-10-22 | — | — | US | disclosed |
| US-20120077226-A1 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS | KIELISZEWSKI MARCIA J (US) | 2012-03-29 | — | — | US | disclosed |
| US-20110003340-A1 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH PROTEINS | KIELISZEWSKI MARCIA J | 2011-01-06 | — | — | US | disclosed |
| US-20100261874-A1 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE RICH GLYCOPROTEINS | OHIO UNIVERSITY (US) | 2010-10-14 | — | — | US | disclosed |
| US-20040009555-A1 | Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics | OHIO UNIVERSITY, TECHNOLOGY TRANSFER OFFICE, TECHNOLOGY AND ENTERPRISE BUILDING | 2004-01-15 | — | — | US | disclosed |
| US-20040009557-A1 | Novel synthetic genes for plant gums | OHIO UNIVERSITY, TECHNOLOGY TRANSFER OFFICE, TECHNOLOGY AND ENTERPRISE BUILDING | 2004-01-15 | — | — | US | disclosed |
| US-6639050-B1 | Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline(Hyp)-rich glycoproteins (HRGPs), repetitive proline-rich proteins (RPRPs) and arabinogalactan-proteins | OHIO UNIVERSITY | 2003-10-28 | — | — | US | disclosed |
| US-6570062-B1 | Nucleotide sequences coding plant gum for use in the generation of disease resistant and drought plants | OHIO UNIVERSITY | 2003-05-27 | — | — | US | disclosed |
| US-6548642-B1 | Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline-rich glycoproteins | OHIO UNIVERSITY | 2003-04-15 | — | — | US | disclosed |
| WO-2001078503-A2 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS | OHIO UNIVERSITY (US) | 2001-10-25 | — | — | WO | disclosed |
| EP-1003840-A1 | SYNTHETIC GENES FOR PLANT GUMS | Ohio University (US) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999003978-A1 | NOVEL SYNTHETIC GENES FOR PLANT GUMS | OHIO UNIVERSITY (US) | 1999-01-28 | — | — | WO | disclosed |
| EP-0736101-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF O-GLYCOSYLATED AMINO ACID OR PEPTIDE OR DERIVATIVES THEREOF | BIOFLEXIN AB (SE) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995018232-A1 | ENZYMATIC METHOD FOR SYNTHESIS OF O-GLYCOSYLATED AMINO ACID OR PEPTIDE OR DERIVATIVES THEREOF | BIOFLEXIN AB (SE) | 1995-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003340-A1 | SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH PROTEINS | PRR12, PRAP1, SGTA | PYGB 1624/4885GAA 360/4885CA12 3036/4885 |
| US-20230256080-A1 | VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS | TP53, LY96, BLK | PYGB 4436/4885GAA 851/4885CA12 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.